You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HLA antibodies

Showing 26 - 50 of 5,169
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Donor-Specific Antibodies in Immunized Living Donor Kidney

Completed
  • Renal Failure
    • (no location specified)
    Jun 28, 2022

    Renal Transplantation Trial in France (Systematic transplantectomy, Progressive reduction of immunosuppression)

    Completed
    • Renal Transplantation
    • Systematic transplantectomy
    • Progressive reduction of immunosuppression
    • Clermont-Ferrand Cedex, France
    • +8 more
    Nov 18, 2022

    Kidney Transplantation, End Stage Kidney Disease (ESRD) Trial in Chicago (Belatacept Injection)

    Recruiting
    • Kidney Transplantation
    • End Stage Kidney Disease (ESRD)
    • Belatacept Injection
    • Chicago, Illinois
      University of Chicago
    May 13, 2022

    Renal Transplant Rejection, Induction Therapy Trial (Rabbit Anti thymocyte globulin (rATG), Basiliximab)

    Not yet recruiting
    • Renal Transplant Rejection
    • Induction Therapy
    • (no location specified)
    Sep 22, 2022

    Lung Transplant Rejection, Antibody-mediated Rejection Trial in Saint Louis, Houston (Belatacept, Tacrolimus, ATG)

    Active, not recruiting
    Has Results
    • Lung Transplant Rejection
    • Antibody-mediated Rejection
    • Saint Louis, Missouri
    • +1 more
    Nov 2, 2021

    Trifecta-Kidney cfDNA-MMDx Study

    Recruiting
    • Kidney Transplant Rejection
    • MMDx
    • +2 more
    • Tampa, Florida
    • +30 more
    Oct 12, 2022

    Non-gal, Non-HLA Antigens in Patients Implanted With Xenogenic

    Recruiting
    • Valve Heart Disease
    • blood draw
    • Phoenix, Arizona
    • +2 more
    Dec 6, 2022

    Kidney Transplant Trial in Toulouse (Blood sampling)

    Completed
    • Kidney Transplant
    • Blood sampling
    • Toulouse, France
      University Hospital
    Aug 19, 2019

    Adult Patients Treated in Study R5459-RT-1944 Who Receive A

    Not yet recruiting
    • Chronic Kidney Disease (CKD)
    • Noninterventional
    • (no location specified)
    Nov 21, 2022

    Liver Transplantation, Graft Failure Trial in Päris (Donor specific antibodies, Serum bank, DNA bank)

    Unknown status
    • Liver Transplantation
    • Graft Failure
    • Donor specific antibodies
    • +4 more
    • Päris, France
      Unité Médicale de Transplantation Hépatique In Service d'Hépato-
    Sep 30, 2019

    Donor Specific B Cells and Antibody Mediated Rejection

    Terminated
    • Sensitized Kidney Transplant Recipients
      • Madison, Wisconsin
        University of Wisconsin Hospital and Clinics
      Dec 13, 2021

      Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in New York (haplo-identical cells (donor), umbilical cord blood unit

      Recruiting
      • Acute Myeloid Leukemia
      • Myelodysplastic Syndrome
      • haplo-identical cells (donor)
      • umbilical cord blood unit (CBU)
      • New York, New York
        Weill Cornell Medical College
      Dec 14, 2022

      Sensitisation, Highly Sensitised Dialysis Patients Trial in La Tronche (Each patient will undergo in the first step of the study

      Recruiting
      • Sensitisation
      • Highly Sensitised Dialysis Patients
      • Each patient will undergo in the first step of the study belatacept treatment and in the second apheresis and daratumumab
      • La Tronche, France
        Chu Grenoble
      May 12, 2022

      MuLtimodality EvaluatiOn of aNtibody mEdiated Damage in Heart

      Active, not recruiting
      • Transplant Failure
      • +2 more
      • Echocardiogram
      • +3 more
      • Majadahonda, Madrid, Spain
      • +2 more
      Jun 14, 2022

      Chronic Kidney Disease (CKD) Trial in New Haven, New York, Philadelphia (REGN5459, REGN5458)

      Not yet recruiting
      • Chronic Kidney Disease (CKD)
      • New York, New York
        New York University Langone Health - Transplant Institute
      Jul 11, 2022

      Anti-HLA Immunization And Immunosuppressive Therapy Management

      Active, not recruiting
      • Kidney Transplantation
      • +3 more
      • management of immunosuppressive therapy
      • Nancy, Lorraine, France
        Central HNF
      Mar 24, 2022

      Diabetes, Type 1 Trial in China (HLA)

      Recruiting
      • Diabetes Mellitus, Type 1
      • HLA
      • Quanzhou, Fujian, China
      • +9 more
      Oct 22, 2022

      Incidence, Course and Outcome of ABMR in Kidney Transplantation

      Not yet recruiting
      • Antibody-mediated Rejection
      • +2 more
      • Kidney Transplantation
      • +2 more
      • (no location specified)
      Nov 17, 2021

      Allosensitization, Heart Transplant Failure and Rejection Trial in Stanford (Daratumumab-SC)

      Recruiting
      • Allosensitization
      • Heart Transplant Failure and Rejection
      • Stanford, California
        Stanford Health Care
      Sep 20, 2021

      Immune Mediated Anemia, Immune Mediated Thrombocytopenia, Chronic GVHD Trial run by the National Heart, Lung, and Blood

      Not yet recruiting
      • Immune Mediated Anemia
      • +2 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Aug 17, 2022

      Renal Cell Carcinoma, NSCLC, Pancreatic Adenocarcinoma, Colorectal Cancer Trial (RO7515629, tocilizumab)

      Not yet recruiting
      • Renal Cell Carcinoma, Non-small Cell Lung Cancer, Pancreatic Adenocarcinoma, Colorectal Cancer
      • (no location specified)
      Mar 3, 2023

      Pancreatic Cancer, Pancreatic Tumors, Pancreatic Ductal Adenocarcinoma Trial in Shanghai (Cyclophosphamide, Fludarabine, Mutant

      Recruiting
      • Pancreatic Cancer
      • +3 more
      • Shanghai, China
        Changhai Hospital
      Jun 13, 2022

      Immunological Reaction of Recipient After Cold-stored Saphenous

      Recruiting
      • Allograft
      • +2 more
      • Blood test
      • Nimes, France
        CHU de Nîmes
      Sep 27, 2022

      Advanced Melanoma Trial in Worldwide (IMC-F106C, Nivolumab, Nivolumab + Relatlimab)

      Not yet recruiting
      • Advanced Melanoma
      • IMC-F106C
      • +2 more
      • La Jolla, California
      • +61 more
      Oct 31, 2023

      Hematopoietic Malignancy, Relapse/Recurrence, Hematopoietic Stem Cell Transplantation Trial in Suzhou (Umbilical Cord Blood

      Recruiting
      • Hematopoietic Malignancy
      • +2 more
      • Umbilical Cord Blood Transplantation
      • Suzhou, Jiangsu, China
        The First Affiliated Hospital of Soochow university
      Nov 6, 2023